These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 10087520)
41. The effectiveness of olanzapine in treatment-refractory schizophrenia when patients are nonresponsive to or unable to tolerate clozapine. Dossenbach MRK ; Beuzen JN; Avnon M; Belmaker RH; Elizur A; Mark M; Munitz H; Schneidman M; Shoshani D; Kratky P; Grundy SL; Tollefson GD Clin Ther; 2000 Sep; 22(9):1021-34. PubMed ID: 11048902 [TBL] [Abstract][Full Text] [Related]
42. [Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine]. Gram LF Ugeskr Laeger; 2000 Mar; 162(13):1914-5. PubMed ID: 10765710 [No Abstract] [Full Text] [Related]
43. Dementia with Lewy bodies in Down's syndrome. Simard M; van Reekum R Int J Geriatr Psychiatry; 2001 Mar; 16(3):311-20. PubMed ID: 11288166 [TBL] [Abstract][Full Text] [Related]
44. Improvement of tardive dyskinesia following treatment with olanzapine. Lykouras L; Malliori M; Christodoulou GN Eur Neuropsychopharmacol; 1999 Jun; 9(4):367-8. PubMed ID: 10422899 [TBL] [Abstract][Full Text] [Related]
45. Severe akathisia during olanzapine treatment of acute schizophrenia. Jauss M; Schröder J; Pantel J; Bachmann S; Gerdsen I; Mundt C Pharmacopsychiatry; 1998 Jul; 31(4):146-8. PubMed ID: 9754850 [TBL] [Abstract][Full Text] [Related]
47. An open trial of olanzapine in the treatment of patients with psychotic depression. Nelson EB; Rielage E; Welge JA; Keck PE Ann Clin Psychiatry; 2001 Sep; 13(3):147-51. PubMed ID: 11791952 [TBL] [Abstract][Full Text] [Related]
49. Neuroleptic malignant syndrome associated with olanzapine therapy: a case report. Stanfield SC; Privette T J Emerg Med; 2000 Nov; 19(4):355-7. PubMed ID: 11074330 [TBL] [Abstract][Full Text] [Related]
50. A clinical case series of six extremely aggressive youths treated with olanzapine. Soderstrom H; Rastam M; Gillberg C Eur Child Adolesc Psychiatry; 2002 Jun; 11(3):138-41. PubMed ID: 12369774 [TBL] [Abstract][Full Text] [Related]
51. [Neuroleptic malignant syndrome in a patient treated with olanzapine]. Horni G; Meirik K; Lund MB Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2867-9. PubMed ID: 14600711 [TBL] [Abstract][Full Text] [Related]
52. Focus on olanzapine. Green B Curr Med Res Opin; 1999; 15(2):79-85. PubMed ID: 10494490 [TBL] [Abstract][Full Text] [Related]
53. [Olanzapine improves chorea in patients with Huntington's disease]. Jiménez-Jiménez FJ; de Toledo M; Puertas I; Barón M; Zurdo M; Barcenilla B Rev Neurol; 2002 Sep 16-30; 35(6):524-5. PubMed ID: 12389168 [TBL] [Abstract][Full Text] [Related]
54. Olanzapine in the treatment of psychotic depression. Malhi GS; Checkley SA Br J Psychiatry; 1999 May; 174():460. PubMed ID: 10616618 [No Abstract] [Full Text] [Related]
55. Are the atypical antipsychotic drugs antidepressants? Parker G; Malhi G J Clin Psychopharmacol; 2002 Feb; 22(1):94-5. PubMed ID: 11799351 [No Abstract] [Full Text] [Related]
56. [Demyelinating disease]. Joko T; Amano N Ryoikibetsu Shokogun Shirizu; 2003; (40):328-31. PubMed ID: 14626132 [No Abstract] [Full Text] [Related]